SCHEMBL2423902

SCHEMBL2423902

CCCOC(=O)c1nnc(-c2ccccc2)s1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.51
CSNK2A2 P19784 3/20 0.50
CSNK2A1 P68400 3/20 0.50
ALOX5 P09917 1/20 0.49
GRM6 O15303 1/20 0.49
ALDH1A1 P00352 3/20 0.49
CDC7 O00311 1/20 0.46
TRPM8 Q7Z2W7 1/20 0.46
DBF4 Q9UBU7 1/20 0.46
ADORA3 P0DMS8 2/20 0.45
DDX3X O00571 1/20 0.45
POLB P06746 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
RARA P10276 1/20 0.42
RARB P10826 1/20 0.42
RARG P13631 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42
TP53 P04637 1/20 0.41
TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2179717 0.88 TRPM8 (0.58) LMNAGRM6ALDH1A1CDC7TRPM8
SCHEMBL2426380 0.80 TRPM8 (0.55) ALDH1A1TRPM8DDX3XPOLBL3MBTL1
SCHEMBL25397707 0.77 TRPM8 (0.58) LMNAALDH1A1CDC7TRPM8DBF4
SCHEMBL2427248 0.77 GRM6 (0.47) LMNAGRM6ALDH1A1TRPM8POLB
SCHEMBL20486119 0.76 NPC1 (0.54) CSNK2A2CSNK2A1ALOX5ALDH1A1POLB
SCHEMBL2425563 0.76 RAB9A (0.55) CSNK2A2CSNK2A1ALOX5ALDH1A1L3MBTL1
SCHEMBL17212202 0.75 CDC7 (0.62) ALDH1A1CDC7DBF4KMT2A
SCHEMBL26524186 0.75 ALDH1A1 (0.49) LMNAALDH1A1CDC7DBF4POLB
SCHEMBL2428586 0.75 ALDH1A1 (0.44) CSNK2A2CSNK2A1ALDH1A1CDC7TRPM8
SCHEMBL8840161 0.74 NPC1 (0.51) CSNK2A2CSNK2A1ALDH1A1DDX3XPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1605752-B1 Sulfonamides for the treatment of congestive heart failure, their compositions and uses. CYTOKINETICS INC (US) 2011-09-14 EP disclosed